VFMF - Vanguard U.S. Multifactor ETF
| Assets | $83.06M |
| NAV | $99.47 |
| Expense Ratio | 0.19% |
| PE Ratio | 18.10 |
| Beta (5Y) | 1.13 |
| Dividend (ttm) | $1.24 |
| Dividend Yield | 1.25% |
| Ex-Dividend Date | Mar 22, 2021 |
| 1-Year Return | - |
| Trading Day | April 16 |
| Last Price | $100.13 |
| Previous Close | $99.41 |
| Change ($) | 0.71 |
| Change (%) | 0.72% |
| Day's Open | 100.00 |
| Day's Range | 99.80 - 100.21 |
| Day's Volume | 3,887 |
| 52-Week Range | 57.03 - 100.21 |
Fund Description
The investment seeks to provide long-term capital appreciation. The fund invests primarily in U.S. common stocks with the potential to generate higher returns relative to the broad U.S. equity market by investing in stocks with relatively strong recent performance, strong fundamentals, and low prices relative to fundamentals as determined by the advisor. Under normal circumstances, at least 80% of its assets will be invested in securities issued by U.S. companies.
| Asset Class Equity | Inception Date Feb 13, 2018 |
| Exchange BATS | Ticker Symbol VFMF |
| Index Tracked MSCI USA Diversified Multi-Factor Index | |
Top 10 Holdings
8.30% of assets| Name | Symbol | Weight |
|---|---|---|
| Target | TGT | 1.03% |
| HCA Healthcare | HCA | 1.02% |
| Apple | AAPL | 0.98% |
| T. Rowe Price Group | TROW | 0.88% |
| eBay Inc. | EBAY | 0.83% |
| Walmart | WMT | 0.75% |
| Humana | HUM | 0.71% |
| Dow Inc | DOW | 0.71% |
| UnitedHealth | UNH | 0.70% |
| Micron Technology | MU | 0.69% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 22, 2021 | $0.25 | Mar 25, 2021 |
| Dec 24, 2020 | $0.4525 | Dec 30, 2020 |
| Sep 21, 2020 | $0.2313 | Sep 24, 2020 |
| Jun 29, 2020 | $0.3093 | Jul 2, 2020 |
| Mar 23, 2020 | $0.3131 | Mar 26, 2020 |
| Dec 20, 2019 | $0.3793 | Dec 26, 2019 |
Factor investing is an alternative to indexing and active investing that has outperformed the market in the past.
The value versus growth debate continues to rage in when it comes to factor investing, but there’s a case to be stated for not only both, but all factors.
About 18 months ago, Vanguard got into factor-based exchange traded funds with six actively managed, though still cost-effective funds.